dalteparin has been researched along with idrabiotaparinux in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eikelboom, JW; Weitz, JI | 1 |
Büller, HR; Gallus, AS; Pillion, G; Prins, MH; Raskob, GE | 1 |
1 trial(s) available for dalteparin and idrabiotaparinux
Article | Year |
---|---|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Biotin; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Factor X; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |
1 other study(ies) available for dalteparin and idrabiotaparinux
Article | Year |
---|---|
Idrabiotaparinux treatment for venous thromboembolism.
Topics: Anticoagulants; Biotin; Enoxaparin; Factor X; Female; Humans; Male; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |